Related Experiment Videos
Current status of liver transplantation
1The Liver Unit, Birmingham Children's Hospital, Steelhouse Lane, Birmingham.
Indian Journal of Pediatrics
|November 19, 2003
Summary
Liver transplantation (LT) offers improved survival for liver failure, with India reporting successful pediatric and adult cases. Key challenges include donor scarcity and optimizing immunosuppression for better patient outcomes.
Area of Science:
- Hepatology
- Transplant Surgery
- Pediatric Gastroenterology
Background:
- Liver transplantation (LT) is a vital treatment for acute and chronic liver failure.
- Improved survival rates in developed nations have increased global awareness and application of LT.
- India has reported successful pediatric and adult LT, indicating growing expertise.
Purpose of the Study:
- To review the current status and challenges of liver transplantation, particularly in the context of developing countries.
- To highlight the common indications, innovative techniques, and outcomes of LT.
- To discuss postoperative complications and future directions in liver transplantation.
Main Methods:
- Review of current literature on liver transplantation outcomes and challenges.
- Analysis of indications, surgical techniques, and complications of LT.
- Discussion of advancements and future research needs in the field.
Main Results:
- Chronic liver failure due to cholestatic liver disease, especially biliary atresia, is the most frequent indication for LT.
- Innovative techniques like reduced-size and living-donor LT are increasingly used to mitigate waiting times and risks.
- Early complications include graft failure, thrombosis, rejection, and infections; late complications involve infections, immunosuppression side effects, and biliary strictures.
Conclusions:
- Successful LT is increasingly reported in India for both children and adults.
- While most children achieve a good quality of life post-LT, significant challenges remain.
- Future efforts must address donor scarcity and develop safer, more effective immunosuppressive agents.